Back to search

Article

The adiposity of CRLM before targeted therapy initiation may serve as a marker to distinguish KRAS mutation status:A retrospective study

2024-03-28

Abstract excerpt

<title>Abstract</title> <p>OBJECTIVE This study aimed to explore the correlation between MRI-related parameters and the Kirsten rat sarcoma viral oncogene (KRAS) gene mutation status in colorectal cancer liver metastases (CRLM) prior to initiating targeted therapy. METHODS This retrospective study enrolled 118 patients diagnosed with colorectal cancer liver metastases, each presenting up to three lesions of the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ecaa7122-eb33-59b4-97d7-6b46511477a0
DOI
10.21203/rs.3.rs-4136576/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The adiposity of CRLM before targeted therapy initiation may serve as a marker to distinguish KRAS mutation status:A retrospective studyDOI 10.21203/rs.3.rs-4136576/v1
Select a neighboring publication to make it the new centre.